Search details
1.
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
N Engl J Med
; 385(5): 395-405, 2021 07 29.
Article
in English
| MEDLINE | ID: mdl-34320285
2.
Explaining risks and benefits of loco-regional treatments to patients.
Breast
; 71: 132-137, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37634470
3.
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12.
Eur J Cancer
; 180: 108-116, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36592505
4.
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Virchows Arch
; 483(1): 5-20, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37330436
5.
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
J Clin Oncol
; 41(33): 5118-5130, 2023 Nov 20.
Article
in English
| MEDLINE | ID: mdl-37556775
6.
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer.
NEJM Evid
; 1(12): EVIDoa2200162, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-38319865
Results
1 -
6
de 6
1
Next >
>>